Benchmark Co. Maintains RXO Inc(RXO.US) With Hold Rating
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Maintains Target Price $30
RXO Analyst Ratings
Wolfe Research Maintains RXO Inc(RXO.US) With Sell Rating, Raises Target Price to $23
RXO Inc. Initiated With a Buy at Citi
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Cuts Target Price to $16
RXO Is Maintained at Negative by Susquehanna
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
TD Cowen Maintains RXO Inc(RXO.US) With Hold Rating, Raises Target Price to $28
RXO Analyst Ratings
Oppenheimer Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $31
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
Barclays Sticks to Its Buy Rating for RXO, Inc. (RXO)
Jefferies Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $31
RXO, Inc. (RXO) Gets a Buy From Jefferies
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $30
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Raises Target Price to $20
RXO Analyst Ratings
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $31 to $32
No Data
No Data